Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide

Gastroenterology

Volumn 101, Issue 2, 1991, Pages 503-511

  Fried, Michael ^a,b,c,d   Erlacher, Urs ^a,b,c,d   Schwizer, Werner ^a,b,c,d   Löchner, Christine ^a,b,c,d   Koerfer, Jacques ^a,b,c,d   Beglinger, Christoph ^a,b,c,d   Jansen, Jan B ^a,b,c,d   Lamers, Cornelis B ^a,b,c,d   Harder, Felix ^a,b,c,d   Bischof Delaloye, Angelika ^a,b,c,d   Stalder, Georg A ^a,b,c,d   Rovati, Lucio ^a,b,c,d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Rotta Research Laboratorium   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; LOXIGLUMIDE;

ADULT; ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; STOMACH EMPTYING;

ADULT; CHOLECYSTOKININ; GASTRIC EMPTYING; HUMAN; LIPASE; MIDDLE AGE; PANCREAS; PANCREATIC POLYPEPTIDE; PROGLUMIDE; SUPPORT, NON-U.S. GOV'T; TRYPSIN;

EID: 0025815331     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(91)90031-F     Document Type: Article

References (36)

1. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels
2. Regulation of gastric emptying in humans by cholecystokinin
3. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man
4. Pharmacokinetics of loxiglumide after single intravenous or oral doses in man
5. Biological effects of a proglumide derivative as a cholecystokinin antagonist in conscious dogs
6. Pharmacological characterization of a new potent and specific nonpolypeptidic cholecystokinin antagonist
7. Anticholecystokinin activities of loxiglumide
8. Pharmacological characterization of a potent cholecystokinin (CCK) antagonist (abstr)
9. Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK
10. Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine
11. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini
12. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists
13. Proglumide analogues: potent cholecystokinin receptor antagonists
14. Structural features of various proglumiderelated cholecystokinin receptor antagonists
15. An improved turbidimetric analysis of polyethyleneglycol utilizing an emulsifier
16. Simple method for estimating trypsin
17. Proposed standard method for measuring lipase activity in serum by a continuous sampling technique
18. Radioimmunoassay of cholecystokinin in human tissue and plasma
19. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog
20. Analysis of gastric emptying data
21. Motility of the stomach and gastroduodenal junction
22. Role of cholecystokinin in regulation of gastrointestinal motor functions
23. Proglumide a cholecystokinin antagonist increases gastric emptying in rats
24. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist
25. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist
26. Action of the cholecystokinin antagonist L364718 on gastric emptying in the rat
27. Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli
28. Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man
29. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK
30. Cholecystokinetic and pancreozymic effect of o-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin
31. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol
32. Protease-specific suppression of pancreatic exocrine secretion
33. Mechanism by which L364718 regulates biological actions of CCK on pancreas (abstr)
34. Release of pancreatic polypeptide in humans by infusion of cholecystokinin
35. Vagal, cholinergic regulation of pancreatic polypeptide secretion
36. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans